|
Leading clinical disease expertise and coordination
|
Royal Liverpool University Hospital (RLUH) (consortium coordinator, study co-sponsor)
|
|
Leading scientific disease expertise
|
University of Liverpool (study co-sponsor)
|
|
Patient perspective and network, advocacy
|
AKU Society, United Kingdom
|
|
Operational clinical study expertise (including Data Management) to conduct complex international clinical studies in rare diseases
|
PSR, the Netherlands
|
|
Clinical research from a regulatory perspective, managing regulatory authority interactions and applications, expertise in the investigational drug and pharmacovigilance
|
Swedish Orphan Biovitrum (Sobi), Sweden
|
|
Medical monitoring expertise
|
Cudos, the Netherlands
|
|
Biomarker analysis expertise
|
Nordic Biosciences, Denmark
|
|
Inflammatory markers analysis expertise
|
Universita degli studi di Siena, Italy
|
|
Genetic analysis expertise
|
Biomedical Research Center of the Slovak Academy of Sciences, Slovakia
|
|
Clinical expertise and study conduct (in addition to RLUH)
|
Hôpital Necker, France (study site)
|
|
Clinical expertise and study conduct (in addition to RLUH)
|
National Institute of Rheumatic Diseases, Slovakia (study site)
|
|
Additional clinical study participants’ support and communication with study participants
|
ALCAP, France
|
